Novavax | NVAX - Umlaufvermögen





Umlaufvermögen Veränderung Datum
Adma Biologics USD 466.51M 63.86M 2025-12
Agenus USD 133.44M 514K 2025-12
AstraZeneca USD 28.72B 1.22B 2025-12
BioCryst Pharmaceuticals USD 404.35M 48.66M 2025-12
Cassava Sciences USD 97.71M 11.2M 2025-12
Geron USD 520.27M 2.07M 2025-12
GlaxoSmithKline GBP 17.51B 332M 2025-12
MannKind USD 291.58M 67.26M 2025-12
Merck USD 47.56B 10.49B 2025-09
Minerva Neurosciences USD 83.1M 70.08M 2025-12
Moderna USD 6.54B 54M 2025-12
Novartis USD 30.46B 2.26B 2025-12
Novavax USD 978.28M 3.69M 2025-12
Pfizer USD 46.92B 3.22B 2025-09
Sanofi EUR 30.95B 3.09B 2025-12
Sarepta Therapeutics USD 2.54B 184.37M 2025-12
TG Therapeutics USD 630.76M 31M 2025-12